Transcriptomics

Dataset Information

0

Combination therapy of NHS-IL12 and avelumab enhances antitumor efficacy in preclinical cancer models

ABSTRACT: Nanostring gene expression profiling of 24 BALB/c mice bearing EMT-6 tumors under avelumab and NHS-muIL12 mono and combination therapies.

ORGANISM(S): Mus musculus

PROVIDER: GSE93192 | GEO | 2017/12/20

SECONDARY ACCESSION(S): PRJNA360272

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models.
| S-EPMC8718653 | biostudies-literature
Unknown Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
| S-EPMC4482855 | biostudies-other
Unknown Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.
| S-EPMC4658168 | biostudies-literature
Genomics Mus musculus
| PRJNA360272 | ENA
Unknown Combination treatment with hypoxia-activated prodrug evofosfamide (TH-302) and mTOR inhibitors results in enhanced antitumor efficacy in preclinical renal cell carcinoma models.
| S-EPMC4548326 | biostudies-literature
Unknown Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models.
| S-EPMC8102325 | biostudies-literature
Unknown Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models.
| S-EPMC5803339 | biostudies-literature
Unknown Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo.
| S-EPMC3293621 | biostudies-literature
Unknown Antitumor efficacy of liposome-encapsulated NVP-BEZ 235 in combination with irreversible electroporation.
| S-EPMC6058606 | biostudies-literature
Unknown Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin-Tetradrine Combination.
| S-EPMC8046896 | biostudies-literature